cyclopentane has been researched along with Cancer of Kidney in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, LS; Jia, L; Li, L; Liang, Y; Liu, L; Liu, X; Wang, J; Wang, S; Wang, X; Yu, J; Zhang, W; Zhang, Y; Zhao, H | 1 |
| Jiang, W; Si, Y; Tong, S; Xie, P; Yu, H; Zhang, L | 1 |
| Bi, R; Chang, J; Deng, Y; Du, Y; Guo, H; Liu, G; Shah, NK; Shu, C; Wang, C; Wei, W; Xu, B | 1 |
| Cuffe, LP; Gallagher, WM; Lou, Y; Mendoza, O; Müller-Bunz, H; Rehmann, FJ; Sweeney, N; Tacke, M | 1 |
| Strohfeldt, K; Tacke, M | 1 |
| Barrero, AF; Christophersen, C; Justicia, J; Malmstrøm, J; Oltra, JE; Rosales, A | 1 |
1 review(s) available for cyclopentane and Cancer of Kidney
| Article | Year |
|---|---|
Bioorganometallic fulvene-derived titanocene anti-cancer drugs.
Topics: Animals; Antineoplastic Agents; Cell Survival; Cyclopentanes; Drug Screening Assays, Antitumor; Inhibitory Concentration 50; Kidney Neoplasms; LLC-PK1 Cells; Molecular Structure; Organometallic Compounds; Swine | 2008 |
5 other study(ies) available for cyclopentane and Cancer of Kidney
| Article | Year |
|---|---|
Targeting neddylation pathway with MLN4924 (Pevonedistat) induces NOXA-dependent apoptosis in renal cell carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Survival; Cyclopentanes; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Kidney Neoplasms; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Structure-Activity Relationship; Tumor Cells, Cultured; Up-Regulation | 2017 |
MLN4924 (Pevonedistat), a protein neddylation inhibitor, suppresses proliferation and migration of human clear cell renal cell carcinoma.
Topics: Apoptosis; Autophagy; Carcinoma, Renal Cell; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Cyclopentanes; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; NEDD8 Protein; Protein Processing, Post-Translational; Proteolysis; Pyrimidines; Tumor Cells, Cultured; Ubiquitins | 2017 |
A first-in-class inhibitor, MLN4924 (pevonedistat), induces cell-cycle arrest, senescence, and apoptosis in human renal cell carcinoma by suppressing UBE2M-dependent neddylation modification.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Renal Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Cyclopentanes; DNA Damage; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Kidney Neoplasms; Mice; Mice, Inbred BALB C; Pyrimidines; Ubiquitin-Activating Enzymes; Ubiquitin-Conjugating Enzymes; Xenograft Model Antitumor Assays | 2018 |
Methoxy-phenyl substituted ansa-titanocenes as potential anti-cancer drugs derived from fulvenes and titanium dichloride.
Topics: Animals; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Cyclopentanes; Drug Evaluation, Preclinical; Inhibitory Concentration 50; Kidney Neoplasms; Molecular Conformation; Swine; Titanium | 2004 |
Bioactive metabolites from a marine-derived strain of the fungus Emericella variecolor.
Topics: Animals; Antibiotics, Antineoplastic; Antifungal Agents; Benzyl Alcohols; Breast Neoplasms; Caribbean Region; Central Nervous System Neoplasms; Colonic Neoplasms; Cyclopentanes; Drug Screening Assays, Antitumor; Ergosterol; Female; Fungi; Furans; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Kidney Neoplasms; Leukemia P388; Lung Neoplasms; Male; Mice; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Porifera; Prostatic Neoplasms; Spectrophotometry, Ultraviolet; Tumor Cells, Cultured; Xanthenes; Xanthones | 2002 |